4 results match your criteria: "Prescription Drug Research Center[Affiliation]"

Efficiency of extraction and conversion of pseudoephedrine to methamphetamine from tamper-resistant and non-tamper-resistant formulations.

J Pharm Biomed Anal

July 2018

Johnson & Johnson Consumer, Inc, 7050 Camp Hill Road, Fort Washington, PA 19034, USA. Electronic address:

Clandestine chemists have demonstrated an ability to convert commercially available pseudoephedrine formulations to methamphetamine. Some of these formulations have properties that manufacturers claim limit or block the extraction of pseudoephedrine and its direct conversion to methamphetamine. In this study, 3 commercially available pseudoephedrine formulations were evaluated for ease of extraction and conversion to methamphetamine using a common chemistry technique called the one-pot method that is frequently employed by clandestine chemists.

View Article and Find Full Text PDF

The supply chain of medicinal controlled substances: addressing the Achilles heel of drug diversion.

J Pain Palliat Care Pharmacother

September 2012

Prescription Drug Research Center LLC, a subsidiary of Bensinger, DuPont & Associates, Inc BDA, Chicago, Illinois, USA.

The escalation of prescription drug abuse in the U.S. has attracted the attention of public health and safety officials as well as others puzzled by how such a tightly regulated enterprise could so easily be breached by those seeking controlled substances for nonmedical use.

View Article and Find Full Text PDF

A recent federal report indicates that prescription drug abuse is now the second leading category of illicit drug use, following marijuana use. Control strategies typically focus on reducing the diversion of prescription drugs from legitimate sources. The proliferation of unregulated Internet sources, however, has rendered control strategies less effective.

View Article and Find Full Text PDF